NPT
NRXP icon

National Philanthropic Trust’s NRX Pharmaceuticals NRXP Stock Holding History

National Philanthropic Trust’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,050
Closed -$24.5K – 267
2024
Q2 		$24.5K Buy
+10,050
New +$35.8K ﹤0.01% 257

Other funds holding NRXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OWMIAS
One Wealth Management Investment & Advisory Services Miami Beach, Florida $95.3M AUM 25.31% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

National Philanthropic Trust's NRXP Position: Q3 2024 in Review

National Philanthropic Trust sold out of NRX Pharmaceuticals (NRXP) in Q3 2024, closing a stake of 10,050 shares — an estimated $24.5K sold.

National Philanthropic Trust first reported a position in NRXP in Q2 2024 and held it in 1 quarter. The position peaked at $24.5K in Q2 2024. 18 funds tracked by Wall St. Rank hold NRXP as of Q3 2024.

  • National Philanthropic Trust reported no remaining NRX Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • National Philanthropic Trust sold 10,050 NRX Pharmaceuticals shares in Q3 2024, an estimated $24.5K.
  • National Philanthropic Trust first reported a position in NRX Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • National Philanthropic Trust's NRX Pharmaceuticals position peaked at $24.5K in Q2 2024.
  • 18 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2024.

Based on National Philanthropic Trust's 13F filing for Q3 2024, filed 15 May 2026.